Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

The Folly Of Burying Great Insight
The Folly Of Burying Great Insight Last week I posted “Why The Wall Street Journal’s U.S. Drug Price Comparison Misses The Mark,” a criticism of health and science deputy bureau chief Jeanne Whalen’s Dec. 1, 2015 article titled, “U.S. Drug Prices Dwarf Other Nations.” What bothered me about this article was that I felt it skewed the facts, sensationalized the issue, and seemed intent on stirring up controversy.  Continue Reading...
FDA/CMS Summit Demonstrates Need For Innovative Hiring Solutions
FDA/CMS Summit Demonstrates Need For Innovative Hiring Solutions When Janet Woodcock, M.D., kicked of this year’s FDA/CMS Summit for biopharmaceutical executives, the FDA’s director for the Center for Drug Evaluation & Research (CDER) did so by recapping what was achieved in 2015, as well as sharing her lengthy list of priorities for the coming year. According to Woodcock, the challenge to successful implementation of various priorities is analogous to keeping an airplane flying while at the...  Continue Reading...
Why The <em>Wall Street Journal’s</em> U.S. Drug Price Comparison Misses The Mark
Why The Wall Street Journal’s U.S. Drug Price Comparison Misses The Mark In the December 1, 2015 edition of the Wall Street Journal there is an article titled, “U.S. Drug Prices Dwarf Other Nations.” The author, health and science deputy bureau chief Jeanne Whalen, begins by pointing out that Norway, an oil producer with one of the richest economies in the world, is an expensive place to live. To support her claim she highlights Norway’s cost of a Big Mac ($5.65) and a gallon of gasoline ($6). But...  Continue Reading...
There’s More To January Than Just the JPM Conference
There’s More To January Than Just the JPM Conference One of the biggest biopharmaceutical industry events, the 34th Annual JP Morgan Healthcare Conference, is right around the corner, January 11-14. And while the event is famous for overrunning San Francisco with neckties, as well as blowing up Twitter with its hashtag #JPM2016, there are a number of other worthwhile events also taking place. For example, just down the street is the 8th Annual Biotech Showcase #BTS2016. In fact, last year my...  Continue Reading...
ISPE Meeting Provides Emotional Rollercoaster
ISPE Meeting Provides Emotional Rollercoaster Stepping out of my hotel room on the last day of the 2015 International Society of Pharmaceutical Engineering (ISPE) annual meeting in Philadelphia (November 8 – 11), I reach down and pick up the USA Today that is blocking my egress. Flipping through the newspaper the headline “Allen Always Aimed High” catches my eye. As writer Nicole Auerbach relates how Duke University basketball standout Grayson Allen strived to achieve his...  Continue Reading...
How Can You Provide Healthcare Value In A Patient-Centric Era?
How Can You Provide Healthcare Value In A Patient-Centric Era? Patients have become more empowered, better informed, and more financially invested in their health and well-being than ever before. As a result, we have seen the healthcare landscape evolve toward a patient-centric delivery model.  Continue Reading...
Does Being Disruptively Innovative Translate Into Being More Patient-Centric?
Does Being Disruptively Innovative Translate Into Being More Patient-Centric? Everyone has experienced poor customer service in one form or another. Say you want to call a company with a question or a complaint about a product. You’re likely to be informed by an automated voice that, “Due to the high volume of calls we are currently experiencing, your anticipated wait time will be X minutes.  For faster and more convenient customer service, please visit our website at www.wedon’tcaretospeaktoyou...  Continue Reading...
The Value Of Biopharma Headhunters — A Comprehensive Executive Resource
The Value Of Biopharma Headhunters — A Comprehensive Executive Resource During a conversation with Pascale Witz, leader of Sanofi’s newly created global divisions and strategic development organization, the former GE executive commented on the value of headhunters (recruiters) in being able to do more than fill talent gaps.   Continue Reading...
How A Twitter KOL List Can Keep Life Sciences Execs Focused
How A Twitter KOL List Can Keep Life Sciences Execs Focused There are plenty of articles out there telling us who to follow on Twitter. For example, Twitter In The Life Sciences: The Ultimate ‘Who To Follow’ Checklist, Fast Company’s take on who the most creative people in business follow, Luke Timmerman’s suggestion on who life science pros should follow, 31 Influential Business Leaders To Follow On Twitter, Top Leadership Experts To Follow In 2015, and so on.  Continue Reading...
Will India Be The Downfall Of The U.S. Biopharma Industry?
Will India Be The Downfall Of The U.S. Biopharma Industry? In September 2014, Gilead announced a generic licensing agreement with then seven India-based generic pharmaceutical manufacturers to increase access to Hepatitis C treatments in developing countries.  Continue Reading...